SP-MET-1

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSP-MET-1
Drug Alias NameSP-MET-X1SP-MET-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein S100-A4 modulators
TargetsProtein S100-A4
Therapy Area/IndicationsColorectal NeoplasmsBreast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSupratek Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSupratek Pharma
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A